JPAG - serving its members since 1970
JPAG plans and delivers events that address all aspects of pharmaceutical analysis and related facets of medicine control & registration.
Dr John Kauffman,
confirmed for the June symposium
Thursday 12th May 2016Sterility assurance best practice for aseptically manufactured productsRoyal Society of Chemistry, London
The purpose of the meeting is to deliver a best practice forum of like-minded professionals engaged in the manufacture of aseptic pharmaceutical products. JPAG have assembled a strong line up of opinion leaders and experts from the UK regulator, the MHRA, industry and the NHS in the field of aseptic manufacture and microbiological monitoring and testing to provide an excellent opportunity for networking and bench marking for delegates.
The meeting will also play host to equipment providers to show the current state of the art in aseptic manufacturing and testing equipment.
James Drinkwater - Pharmaceutical and Healthcare Sciences Society
Dawn Hiles - Newcastle Cellular Therapies Facility, International Centre for Life
Andrew Hopkins - Expert GMDP Inspector, MHRA
Dr Aileen Hume - AMRI
Yan Hunter-Blair - Newcastle upon Tyne NHS Foundation Trust
Dr Paul Newby - GlaxoSmithKline
Dr Tim Sandle - Bio Products LaboratoryDETAILS AND BOOKING
Thursday 23rd June 2016Practical implementation of ICH Q3D; challenges and solutionsRoyal Society of Chemistry, London
This symposium will critically examine the practical challenges associated with effective implementation of ICH Q3D
Dr John Kauffman, FDA
Sven-Erik Hillver, Swedish MPA
Dr Andrew Teasdale, AstraZeneca
Dr Laurence Harris, Pfizer
Samuel Powell, Pfizer
Dr Michael James, GSK
Kevin Hughes, ColorconDETAILS AND BOOKING
Thursday 13th October 2016Good Distribution Practice: solving implementation and quality issuesRoyal Society of Chemistry, London LAST EVENT:
In a globalised healthcare ecosystem, supply chains become more complex, with an increased potential for quality issue to arises.
So, it is critically important to understand Good Distribution Practices (GDP) and the requirements for shared responsibilities throughout the entire supply chain.
This symposium will examine the regulatory requirements of GDP, provide an understanding of the issues and demonstrate how common problem can be overcome.DETAILS AND BOOKING
EXTERNAL EVENT: Wednesday 20th April 2016Advances in Process Analytics and Control TechnologyCrowne Plaza Hotel, Chester
APACT 16 is a 3-day conference.DETAILS AND MATERIALS
Follow and Like us on Social media
Delegates of any JPAG symposia can access the speakers presentations.
Just SIGN IN, go to RESOURCES and look in MY PAST MEETINGS.
Missed the meeting?
You can access a short report of recent meetings!
Just go to the MEETINGS page, go to PAST MEETINGS 2011-present. Then select the DETAILS for the meeting that interests you.
And do be sure to check the list of upcoming meetings so that you don't miss the next one!
European Pharmaceutical ReviewTESTIMONIALS:Excellent meeting, challenging and thought provoking. The organisation was excellent, thanks to all the efforts that JPAG team have made (March 2015)
JPAG members can receive a free hard copy subscription to EPRclick here
I have not attended a bad JPAG meeting yet. They are really good value for money and I really love to get the presentations as PDFs (June 2015)
The evolving pharmacopoeia
Here is the latest article in the series reproduced with permission from the European Pharmaceutical Review. It is entitled "The evolving pharmacopoeia" written by Dr Dave Elder, Chairman of the JPAG Committee and GSK. More...Monday 29th February 2016
Dissolution testing in the modern world
Here is the latest article in the series reproduced with permission from the European Pharmaceutical Review. It is entitled "Dissolution testing in the modern world?" written by Juliet Symonds, GSK and Dr Dave Elder, Chairman of the JPAG Committee an...More...Monday 29th February 2016
Use of the purge tool in assessing mutagenic impurities
Here is the latest article in the series reproduced with permission from the European Pharmaceutical Review. It is entitled "Importation testing: an unnecessary burden on industry?" written by Dr Dave Elder, Chairman of the JPAG Committee and GSK. More...Wednesday 23rd December 2015
However, it does securely hold details for those who register an account.
This information is only used by JPAG as described in the Privacy Statement (see link on footer below).